PIM1 Human shRNA Plasmid Kit (Locus ID 5292)
CAT#: TG315503
PIM1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | PIM1 Human shRNA Plasmid Kit (Locus ID 5292) |
Locus ID | 5292 |
UniProt ID | P11309 |
Synonyms | PIM |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | PIM1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 5292). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001243186, NM_002648, NM_002648.1, NM_002648.2, NM_002648.3, NM_001243186.1, BC020224, NM_001243186.2, NM_002648.4 |
Summary | The protein encoded by this gene belongs to the Ser/Thr protein kinase family, and PIM subfamily. This gene is expressed primarily in B-lymphoid and myeloid cell lines, and is overexpressed in hematopoietic malignancies and in prostate cancer. It plays a role in signal transduction in blood cells, contributing to both cell proliferation and survival, and thus provides a selective advantage in tumorigenesis. Both the human and orthologous mouse genes have been reported to encode two isoforms (with preferential cellular localization) resulting from the use of alternative in-frame translation initiation codons, the upstream non-AUG (CUG) and downstream AUG codons (PMIDs:16186805, 1825810).[provided by RefSeq, Aug 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372
,An, J;Xu, J;Li, J;Jia, S;Li, X;Lu, Y;Yang, Y;Lin, Z;Xin, X;Wu, M;Zheng, Q;Pu, H;Gui, X;Li, T;Lu, D;,
Oncotarget
,PubMed ID 28467776
[PIM1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...